All In MedTech

Device Trial Radar · NCT01066780

ClearVoice Sound-processing Strategy for AB HiRes 120 Cochlear Implant Users

Evaluation of the ClearVoice™ Strategy in Adults Using HiResolution® Fidelity 120® Sound Processing

Last checked: Nov 20, 2026Latest source record: Jul 22, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

48

Actual

Start

Mar 2010

Primary completion

Sep 2010

Study completion Sep 2010

Sponsor

Lead sponsor
Advanced BionicsNot on our public-company list
Sponsor type
Industry
First posted
Feb 10, 2010

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to collect information about how the new sound-processing affects the ability to hear in everyday listening situations.

Conditions

  • Implant

Interventions

  • ClearVoiceDevice

    ClearVoice is a sound processing strategy designed to improve listening ability in some challenging everyday listening environments for users of the Harmony® HiResolution® Bionic Ear System (Harmony®)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Speech Perception of Standardized Sentences Presented From Recorded Format in Speech-spectrum NoiseTime frame: 4 Weeks

Locations

11 sites in 2 countries. Site status is shown where the registry gives one.

  • House Ear Clinic

    Los Angeles, California

  • Carle Clinic Association

    Urbana, Illinois

  • University of Kentucky

    Lexington, Kentucky

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.